Drugs Made In America Acquisition Corp. - RIGHT 10/15/2029 (DMAAR) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / RIGHT 10/15/2029
Symbol
DMAAR on Nasdaq
Price per share
$0.13
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
16,870,296
Total reported value
$3,023,717
% of total 13F portfolios
0%
Share change
-105,484
Value change
-$18,500
Number of holders
31
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 31 Dec 2025, 31 institutional investors reported holding 16,870,296 shares of Drugs Made In America Acquisition Corp. - RIGHT 10/15/2029 (DMAAR).

Institutional Holders of Drugs Made In America Acquisition Corp. - RIGHT 10/15/2029 (DMAAR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 16,870,296 $3,023,717 -$18,500 $0.19 31
2025 Q3 17,746,646 $7,163,761 +$3,207,692 $0.22 33
2025 Q2 18,277,728 $2,217,081 +$501,584 $0.12 24
2025 Q1 14,151,554 $2,529,405 +$2,529,405 $0.13 19